Search 7,500+ licensed pharmacies to find the best value, closest location, and fastest turnaround for
.
Anastrozole inhibits aromatase — the enzyme that converts testosterone to estradiol. By reducing aromatase activity, it lowers circulating estrogen levels in men and women, reducing estrogen-related side effects during TRT and hormone therapy.
Commercial anastrozole (Arimidex) comes only in 1mg tablets. Men on TRT typically need 0.25–0.5mg doses — only achievable through compounding. Custom doses allow precise estrogen management without over-suppression.
Compare up to 7,500 pharmacies across the USA.
Anastrozole is a potent, selective non-steroidal aromatase inhibitor (AI) originally developed for hormone receptor-positive breast cancer in postmenopausal women. In men's health, it has become a cornerstone of TRT management — used to control estradiol levels that rise as exogenous testosterone aromatizes.
Men on TRT commonly experience elevated estradiol, causing symptoms including water retention, mood changes, reduced libido, gynecomastia, and erectile dysfunction. Anastrozole suppresses aromatase activity, reducing estradiol conversion and managing these side effects.
Commercial anastrozole is only available in 1mg tablets — far too high for most TRT protocols. Compounding allows precise doses of 0.1–0.5mg, enabling tight estrogen management without over-suppression (which causes joint pain, low libido, and cardiovascular risk).
Aromatase Inhibition
Anastrozole competitively binds to the aromatase enzyme (CYP19A1), blocking the conversion of androgens (testosterone, androstenedione) to estrogens (estradiol, estrone). At therapeutic doses it reduces circulating estradiol by 70–80%.
Dose Sensitivity in Men
Men require far lower doses than women with breast cancer. Over-suppression of estradiol causes joint pain, bone loss, cognitive impairment, cardiovascular risk, and paradoxically — low libido. Precise low dosing via compounding is essential.
TRT Management: Estradiol control during testosterone replacement therapy
Gynecomastia: Prevention and treatment of estrogen-driven breast tissue growth in men
Breast Cancer: Adjuvant treatment for hormone receptor-positive breast cancer in postmenopausal women (standard commercial use)
Fertility: Off-label use in men to raise testosterone and improve sperm parameters
TRT estrogen management: 0.25–0.5mg taken 2–3x per week (dosed with testosterone injections)
Gynecomastia: 0.5–1mg daily until resolution
Dosing must be guided by labs — estradiol (sensitive assay for men) should be maintained between 20–40 pg/mL. Avoid over-suppression.
From over-suppression of estradiol (most common issue in men):
Direct side effects:
Submit a quote request to find the lowest price. Quotes delivered to your inbox.
Find Lowest Price.png){kind=spacer}
